These Biotechs Are Surging Along With Coronavirus Infections

As the number of cases of infection by the novel coronavirus around the world rises, so are shares of a number of biotech companies with exposure to experimental vaccines (as was the case a few years back during the Ebola crisis). For four such biotech stocks โ€“ two of which are up over 250% since the beginning of the year โ€“ CLICK HERE.

You may also like